Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Guiot (Liège, Belgium), D. Zanella (Liège, Belgium), P. Stefanuto (Liège, Belgium), L. Giltay (Liège, Belgium), M. Henket (Liège, Belgium), F. Guissard (Liège, Belgium), C. Moermans (Liège, Belgium), F. Schleich (Liège, Belgium), R. Louis (Liège, Belgium), J. Focant (Liège, Belgium). Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis. 3545

Member's Comments

No comment yet.

Related content which might interest you: Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity? Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients? Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide Source: Guideline 2005 Year: 2005 Use of Telemetry and Plethysmography to Assess Respiratory Function in Conscious Rats with Bleomycin-Induced Lung Fibrosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Respiratory Symptoms and Lung Function Depend on Smoking Status and Enviromental Conditions Source: International Congress 2017 – Smoking, apnoea, infection, allergens and other factors Year: 2017 Aerobic and Weightlifting Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Overweight Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Ozone and Sensitization Alter Airway and Nerve-associated Eosinophils Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Marathon Running Modulates Lung Mechanics and Pulmonary and Systemic Immune Response in Amateur Athletes Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020